Pharma News, 2022

Next month, GlaxoSmithKline will complete its de-merger, forming two companies, New GSK, a pharma-focused business, and Haleon, a stand-alone consumer health operation. 

How much could a human genome cost? The answer is $100, according to newly unveiled biotech company Ultima Genomics.

Bristol Myers Squibb (BMS) has announced late-breaking data showing deucravacitinib significant efficacy at the primary endpoint for the treatment of systemic lupus erythematosus (SLE). ...

GSK said today it would pay up to $3.3 billion to acquire privately held biopharma firm Affinivax to bolster its vaccine pipeline, a key area of focus as the British drugmaker prepares to separate ...

Eton Pharma said yesterday the US Food and Drug Administration (FDA) declined to approve its anti-seizure drug lamotrigine, sending the drugmaker’s shares down 13 per cent in extended trading. ...

After recording a 200 per cent growth in Foreign Direct Investment (FDI) equity inflow into the sector in the previous year, foreign equity infusion into the drugs and pharmaceutical industry in In...

The European Commission has given conditional approval to Janssen’s chimeric antigen receptor (CAR) T-cell therapy Carvykti (ciltacabtagene autoleucel) for relapsed and refractory multiple myelo...

Research suggests that individuals receiving a vaccine, such as ones from AstraZeneca and Johnson & Johnson, were more vulnerable to infection by new variants. ...

Treatment with nirogacestat resulted in a 71% reduction in the risk of disease progression among adults with progressing desmoid tumors.

Hyundai Bioscience, a biotechnology company that developed and commercialized bio-fusion technology with the purpose of delivering active ingredients safely and efficiently to the body, has decide...

The FDA has approved Servier Pharmaceuticals’ Tibsovo (ivosidenib) in combination with Bristol Myers Squibb’s Onureg (azacitidine) to treat patients 75 years and older with newly diagnosed iso...

Pfizer Inc. (NYSE: PFE) announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Pfizer’s investigational combination therapy for the treatment of non-alcoholi...